Ann: PEAK-TV Interview, page-48

Reason LSH can go at this snails pace if needed is cause they're the only medically certified platform. Which is the main legislative issue for anyone trying to enter the German market.
Whether its Apple, Google or GMV trying to enter the space, theyll all need at least 6months to certify their platforms. So technically speaking we are 6months ahead of any potential competition.

Co's like GMV, ALC, MDR etc. all dont have certified platforms.
RSH is the only company I could find with a CE approved platform. But they're only limited to asthma monitoring software sitting at $17.8M EV, no revenue and no major deals with multinationals.
Hence why I see a decent Risk v Reward on LSH at these levels trading at $7.7M EV, which has been the consequence of weak hands has potentially provided a good opportunity.